The High Costs of Inaction: Obesity’s Impact on Canada’s Economy and Workforce
Obesity rates in Canada have reached significant levels, with nearly one in three Canadians living with the chronic disease. Obesity Canada conducted an economic analysis to determine the financial burden of untreated obesity on Canada’s healthcare system and the workplace.
The findings demonstrate that a failure to recognize obesity as a chronic and progressive disease, combined with a lack of access to effective treatment and prevention strategies, has resulted in substantial economic implications across the country.
Specifically, the report found:
- The cost of inaction in treating obesity surpassed $27 billion in 2023 – 20% higher than previous estimates.
- The incremental annual cost on Canada’s healthcare system due to obesity was $5.9 billion and is associated with 19 million more physician visits among other care and support needs.
- Indirect costs reached an estimated $21.7 billion due to increased workplace absenteeism, lower workplace presenteeism, obesity-related disability pension payments, premature deaths attributable to obesity, and lower incomes.
- Women living with obesity are 5.3% less likely to be employed compared to women of healthy weight. This disparity is far less pronounced for men, at only 0.3%, despite more men living with obesity.
Top-line findings from Modeling the Cost of Inaction in Treating Obesity in Canada, a report commissioned by Obesity Canada and funded by Eli Lilly Canada, emphasizes the urgent need for effective Canada-wide public health strategies to treat and prevent obesity.
Investing in effective obesity treatment and prevention strategies is not only the right thing to do for Canadians living with the chronic disease, but is crucial for the economic well-being of Canada.
View our Briefing Event
Find more information